SOURCE: CFN Media

CFN Media

February 24, 2017 09:02 ET

Canadian Cannabis Task Force Cites Impaired Driving as a Serious Issue Demanding Immediate Attention -- CFN Media

SEATTLE, WA--(Marketwired - Feb 24, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing the Canadian Cannabis Task Force's recommendations for addressing impaired driving, and Cannabix Technologies' (OTC PINK: BLOZF) position in the emerging cannabis breathalyzer market.

Canada has become the epicenter of the cannabis industry with the country-wide legalization of medical and soon-to-be recreational marijuana. Justin Trudeau's liberal government may be the driver behind these drug laws, but the drug's legalization has been carefully planned from start to finish.

In December, the Canadian Cannabis Task Force issued its final report that contains more than 80 recommendations for the government to consider when legalizing recreational marijuana. Section 4.5 of the final report describes the controversy surrounding marijuana-impaired driving and the public safety risks. In addition to discussing these risks, the report made several recommendations for addressing the key issue before legalizing the drug.

In particular, the fifth recommendation issued by the task force reads:

"Support the development of an appropriate roadside drug screening device for detecting THC levels and invest in these tools."

Cannabix Technologies is developing a marijuana breathalyzer in conjunction with the Yost Research Group at the University of Florida that leverages mass spectrometry technologies for accurate detection of THC. The company holds an exclusive worldwide license of the University of Florida U.S. Patent 8,237,118 in the area of breath analysis of controlled substances, while leveraging a unique approach to detecting THC in breath samples. The technology is powered by high-field asymmetric waveform ion mobility spectrometry (FAIMS), which is capable of identifying THC in ultra-low ranges using highly sensitive equipment. Over the past few quarters, Cannabix has significantly reduced the size of its technology so that it can be eventually used by law enforcement to identify impaired drivers at roadside.

Since introducing its second beta version in late-2016, the company announced that it has significantly improved reliability, reduced the size, and made the design more rugged. The team plans to begin pre-trial live subject testing in March, which represents an important precursor to further testing and development. Data from live subjects will provide valuable information to regulatory bodies.

Please follow the link to read the full article: http://www.cannabisfn.com/canadian-cannabis-task-force-cites-impaired-driving-as-a-serious-issue-demanding-immediate-attention/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the U.S. and Canada rely on CFN Media to grow and succeed.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Contact Information